FASN and breast carcinoma: Several studies have suggested fatty acid synthase (FASN) as a potential molecular target in the treatment of cancers, especially breast cancer (Rysman et al., 2010; Ventura et al., 2015; Gonzalez-Guerrico et al., 2016).